ArticleEnvironment & health (Washington, D.C.)2025
Organophosphate Flame Retardants, Obesity, and Depressive Symptoms among 1019 Young Healthy Men.
Article in Environment & health (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An Exploration of Machine Learning Methods in Human Biomonitoring.International journal of environmental research and public health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Organophosphate flame retardants (OPFRs) can increase fat accumulation and exert neurotoxic effects. In this study, we enrolled 1019 young men who provided 3,550 urine samples over a 3-month follow-up period. We measured nine OPFR metabolite concentrations in urine samples and assessed depressive symptoms using the Beck Depression Inventory questionnaire. In the fully adjusted linear regression models, a 2.7-fold increase in urinary diphenyl phosphate (DPHP) concentrations was associated with a 0.44 unit (95% confidence interval (CI): 0.06, 0.82) higher depressive symptom scores. When men were categorized as having any depressive symptoms (score: > 10 vs ≤ 10), Poisson regression models showed an increased risk of depression across DPHP tertiles (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.